Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD

Blood (2015) 126 (23): 3279.

https://doi.org/10.1182/blood.V126.23.3279.3279

Published: 2015

Journal Articles

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Wendy Y Cheng, MPH, MPhil, Agnihotram V Ramanakumar, PhD, Jonathan Fortier, MA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Patricia Adams-Graves, MD

Blood (2014) 124 (21): 2177.

https://doi.org/10.1182/blood.V124.21.2177.2177

Published: 2014

Journal Articles

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Francis Vekeman, MA, Wendy Y Cheng, MPH, MPhil, Medha Sasane, BPharm, PhD, Lynn Huynh, MPH, MBA, DrPH, Michael Kaminsky, BA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 2964.

https://doi.org/10.1182/blood.V122.21.2964.2964

Published: 2013

Journal Articles

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

Morey A. Blinder, MD, Medha Sasane, BPharm, PhD, Jonathan Fortier, MA, Carole S. Paley, MD, Mei S. Duh, ScD, MPH, Francis Vekeman, MA

Blood (2013) 122 (21): 2927.

https://doi.org/10.1182/blood.V122.21.2927.2927

Published: 2013

Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH

Blood (2013) 122 (21): 982.

https://doi.org/10.1182/blood.V122.21.982.982

Published: 2013

Journal Articles

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Morey A. Blinder, MD, Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Alex Trahey, BS, Carole Paley, MD, Matthew Magestro, MBA, MS, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 475.

https://doi.org/10.1182/blood.V120.21.475.475

Published: 2012

Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 2106.

https://doi.org/10.1182/blood.V120.21.2106.2106

Published: 2012

Journal Articles

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD

Blood (2011) 118 (21): 338.

https://doi.org/10.1182/blood.V118.21.338.338

Published: 2011

Journal Articles

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD

Blood (2011) 118 (21): 12.

https://doi.org/10.1182/blood.V118.21.12.12

Published: 2011

Journal Articles

Costs to Medicare of Treating Chronic Lymphocytic Leukemia Patients with Alemtuzumab.

Marie-Hélène Lafeuille, MA, Francis Vekeman, MA, Matthew Kerrigan, PhD, Si-Tien Wang, Mei Duh, MPH, ScD

Blood (2009) 114 (22): 2477.

https://doi.org/10.1182/blood.V114.22.2477.2477

Published: 2009

Journal Articles

Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.

Lanetta B Jordan, MD, MPH, MSPH, Francis Vekeman, MA, Anirban Sengupta, PhD, Mitra Corral, MPH, MS, Amy Guo, PhD, Mei Sheng Duh, MPH, ScD

Blood (2009) 114 (22): 1982.

https://doi.org/10.1182/blood.V114.22.1982.1982

Published: 2009

Journal Articles

Comparison of Infection-Related Hospitalization Risk and Associated Costs among Patients Receiving Sargramostim (Leukine®), Filgrastim (Neupogen®), and Pegfilgrastim (Neulasta®) for Chemotherapy-Induced Neutropenia

Edmond L Toy, PhD, Francis Vekeman, MA, François Laliberté, MA, Bree Dority, PhD, Daniel Perlman, Victoria Barghout, MSPH, Mei Sheng Duh, MPH, ScD, Mark Lawrence Heaney, MD, PhD

Blood (2008) 112 (11): 665.

https://doi.org/10.1182/blood.V112.11.665.665

Published: 2008

Journal Articles

Comparison of Epoetin Alfa and Darbepoetin Alfa Dosing and Costs in an Inpatient Population with Myelodysplastic Syndromes

Marie- Hélène Lafeuille, BA, Francis Vekeman, MA, Robert A. Bailey, MD, R. Scott Mckenzie, MD, Patrick Lefebvre, MA

Blood (2008) 112 (11): 1297.

https://doi.org/10.1182/blood.V112.11.1297.1297

Published: 2008

Journal Articles

Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naïve Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis

Suneel Mundle, PhD, Patrick Lefebvre, MA, Francis Vekeman, MA, Mei Sheng Duh, MPH, ScD, François Laliberté, MA, Ruchi Rastogi, PharmD, Victor Moyo, MD

Blood (2008) 112 (11): 5074.

https://doi.org/10.1182/blood.V112.11.5074.5074

Published: 2008

Journal Articles

Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.

Francis Vekeman, MA, Brahim K. Bookhart, MBA, MPH, Mei S. Duh, ScD, MPH, Scott R. McKenzie, MD, Patrick Lefebvre, MA, Catherine Tak Piech, MBA

Blood (2007) 110 (11): 2896.

https://doi.org/10.1182/blood.V110.11.2896.2896

Published: 2007

Journal Articles

Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.

Suneel Mundle, PhD, Patrick Lefebvre, MA, Mei S. Duh, ScD, MPH, Francis Vekeman, MA, Behin Yektashenas, PharmD, Francois Laliberté, MA, Victor Moyo, MD

Blood (2007) 110 (11): 1471.

https://doi.org/10.1182/blood.V110.11.1471.1471

Published: 2007

NARROW

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Costs to Medicare of Treating Chronic Lymphocytic Leukemia Patients with Alemtuzumab.

Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.

Comparison of Infection-Related Hospitalization Risk and Associated Costs among Patients Receiving Sargramostim (Leukine®), Filgrastim (Neupogen®), and Pegfilgrastim (Neulasta®) for Chemotherapy-Induced Neutropenia

Comparison of Epoetin Alfa and Darbepoetin Alfa Dosing and Costs in an Inpatient Population with Myelodysplastic Syndromes

Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naïve Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis

Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.

Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only